| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/09/2003 | CN1429222A 激酶抑制剂 Kinase inhibitors |
| 07/09/2003 | CN1429116A Pharmaceutical composition |
| 07/09/2003 | CN1429113A Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 07/09/2003 | CN1428428A Biological reactor using peanut cotyledon as object protein production platform |
| 07/09/2003 | CN1428349A Application of tribulus spirosteroid saponin compound in preparation of antifungal medicine |
| 07/09/2003 | CN1428172A Antiviral Chinese medicine and its preparation method |
| 07/09/2003 | CN1428168A Formula of liquid medicine for curing various intermediate and late cancers and AIDS |
| 07/09/2003 | CN1428166A Chinese medicine composition for curing AIDS and its preparation mehtod |
| 07/09/2003 | CN1428148A Preparation of alternate pseudomonads ecological microbial preparation and its application in marine culture |
| 07/09/2003 | CN1113885C Process for producing beta-lactam derivs. |
| 07/09/2003 | CN1113870C Preparation of butylthio-isoquinoline and intermediate thereof |
| 07/09/2003 | CN1113862C Arysulfonylamino hydroxamic acid derivs. |
| 07/09/2003 | CN1113653C Use of leukotriene B4 or its analogues as antiviral and antineoplastic agents |
| 07/09/2003 | CN1113650C Drug composition of self-emulsifying agent form lipophilic compounds |
| 07/09/2003 | CN1113647C Polyether antitoxin medicine use for antituberculosis and antileprosy |
| 07/09/2003 | CN1113599C Antimicrobial treatment method for herpes simplex virus and other infectious diseases |
| 07/08/2003 | US6590083 Compounds of given formula; erythromycin derivatives; useful in the treatment of bacterial and protozoal infections and conditions involving gastric motility |
| 07/08/2003 | US6589993 Treating vancomycin-intermediates and multiresistant staphylococci infection with thiamphenicol or a salt thereof |
| 07/08/2003 | US6589978 Therapy for nervous system disorders |
| 07/08/2003 | US6589977 Bisindolylpyrrole derivatives represented by general formula (I) which are useful in inhibiting cell death and expected as being useful as preventives and remedies for the progress of various diseases in the progress and worsening of which cell |
| 07/08/2003 | US6589955 Pediatric formulation of gatifloxacin |
| 07/08/2003 | US6589954 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful |
| 07/08/2003 | US6589939 Camptothecin derivatives having antitumor activity |
| 07/08/2003 | US6589748 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample |
| 07/08/2003 | US6589570 Pharmaceutical formulation useful for the treatment of hepatitis B, hepatitis C and other viral infections of the liver and a process for its preparation |
| 07/08/2003 | US6589536 Soft gelatin capsule manufacture |
| 07/08/2003 | US6589533 Able to span or correctly integrate into cell membrane of insects but not mammals |
| 07/08/2003 | US6589532 Papilloma viruses, means for the detection thereof and therapy for diseases caused thereby |
| 07/08/2003 | US6589530 Hepatitis B surface antigen vaccine |
| 07/08/2003 | US6589529 Recombinant fusion proteins as immunogens; VP6 protein or carboxy- terminal fragment |
| 07/08/2003 | US6589503 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 07/08/2003 | US6589286 Eustachian tube stent |
| 07/08/2003 | CA2286511C Novel macrolide derivatives |
| 07/08/2003 | CA2254682C Method of treating eye infections with azithromycin |
| 07/08/2003 | CA2140428C Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof |
| 07/03/2003 | WO2003054197A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 07/03/2003 | WO2003054077A1 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 07/03/2003 | WO2003054017A2 Mono-and dual chemokine/cytokine constructs |
| 07/03/2003 | WO2003054012A2 Leptin proteins |
| 07/03/2003 | WO2003054009A2 Apoptotically active peptides |
| 07/03/2003 | WO2003054001A2 Method for preparing echinocandin derivatives and their compositions |
| 07/03/2003 | WO2003053989A1 Masked phosphate containing nucleoside derivatives and their use as antivirals |
| 07/03/2003 | WO2003053975A1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity |
| 07/03/2003 | WO2003053972A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | WO2003053971A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | WO2003053959A1 Heterocyclylamino carbonyluracils |
| 07/03/2003 | WO2003053955A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 07/03/2003 | WO2003053933A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 07/03/2003 | WO2003053919A1 Substituted cyclohexane derivatives |
| 07/03/2003 | WO2003053915A2 Compounds for the treatment of inflammatory disorders |
| 07/03/2003 | WO2003053522A1 Methods of treating bacterial infections in dogs and cats |
| 07/03/2003 | WO2003053468A1 Method for obtaining the elimination of integrated and functional viruses from infected mammal cells |
| 07/03/2003 | WO2003053467A1 Drug for regenerating tissue and vessel and method therefor |
| 07/03/2003 | WO2003053463A2 Poxvirus-containing compositions and process for their preparation |
| 07/03/2003 | WO2003053450A1 Ribavirin granulate for producing coated tablets |
| 07/03/2003 | WO2003053435A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 07/03/2003 | WO2003053423A2 Inhibition or prevention of infection by bacteria with epa, dha or analogs |
| 07/03/2003 | WO2003053407A1 Liposomal delivery of vitamin e based compounds |
| 07/03/2003 | WO2003053400A1 Formulation & dosage form for the controlled delivery of therapeutic agents |
| 07/03/2003 | WO2003053399A2 Methods for wet granulating azithromycin |
| 07/03/2003 | WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 07/03/2003 | WO2003053360A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/03/2003 | WO2003053332A2 Composition and method for treating viral infection |
| 07/03/2003 | WO2003040684A3 Screening for antiviral affecting signal peptidase |
| 07/03/2003 | WO2003026767A3 Lysin-deficient bacteriophages having reduced immunogenicity |
| 07/03/2003 | WO2003013440A3 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 07/03/2003 | WO2002079147B1 Inhibitors of prenyl-protein transferase |
| 07/03/2003 | WO2002050279A3 Nucleic acid-associated proteins |
| 07/03/2003 | WO2002024754A8 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 07/03/2003 | WO2002020049A3 Eiav chimeric vaccine and diagnostic |
| 07/03/2003 | WO2001098365A3 Peptide and polypeptide inhibitors of complement c1s |
| 07/03/2003 | US20030125532 Kneading then irradiating paste to form elastic gel; microbiocides |
| 07/03/2003 | US20030125531 Arylation method for the functionalization of O-allyl erythromycin derivatives |
| 07/03/2003 | US20030125519 Ligand for the c-kit receptor and methods of use thereof |
| 07/03/2003 | US20030125518 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 07/03/2003 | US20030125384 Administering agent that selectively inhibits bacterial DNA replication initiation; for disease or disorder caused by or associated with E. coli or H. pylori infection |
| 07/03/2003 | US20030125383 For treating or preventing emphysema, cancer and dermatological disorders |
| 07/03/2003 | US20030125376 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 07/03/2003 | US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor |
| 07/03/2003 | US20030125367 Administering a patient with bacterial infections a oxazolidinones having a bicylcic/3.1.0/ hexane containing group as antibiotic |
| 07/03/2003 | US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis |
| 07/03/2003 | US20030125348 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide |
| 07/03/2003 | US20030125340 3-(Amino-or aminoalkyl) pyridinone derivatives and their use for the treatment of HIV related diseases |
| 07/03/2003 | US20030125337 Enhancing the antibacterial action of fluoroquinolones by contacting a bacterium with an indole, a urea, an aromatic amide or a quinoline |
| 07/03/2003 | US20030125331 Treating drug-resistant HIV |
| 07/03/2003 | US20030125330 Anxiolytics and antidepressants |
| 07/03/2003 | US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 07/03/2003 | US20030125313 Prophylaxis/treatment of respiratory system disorders; administered by inhalation; potentiation; reversible airways obstruction, e.g., asthma, chronic obstructive pulmonary diseases (COPD) (e.g. bronchitis, emphysema); infections |
| 07/03/2003 | US20030125286 Transcriptional silencer protein NRF |
| 07/03/2003 | US20030125281 Compositions and processes using siRNA, amphipathic compounds and polycations |
| 07/03/2003 | US20030125267 A bicyclic heteroaromatic compound containing two keto, two ester, a carbamate groups and a methyl, hydroxy and amine substituted oxypyran ring; useful antibacterial agent for treating pneumonia, skin, soft tissue and bone infections |
| 07/03/2003 | US20030125266 Administering a 14 membered macrolide and ketolide antibiotics containing C12 modifications to a patient suffering from bacterial infections |
| 07/03/2003 | US20030125262 Methods and reagents for regulation of cellular responses in biological systems |
| 07/03/2003 | US20030125259 Administering to the mammal a therapeutically acceptable amount of a octa or nonapeptide compound to inhibit the angiogenesis |
| 07/03/2003 | US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 07/03/2003 | US20030125241 Oligonucleotides for treatment of infectious diseases and disorders caused by viruses, bacteria, protozoa or fungi. Administration of an LNA-modified oligonucleotide modulates expression of a targeted gene associated with the replication |
| 07/03/2003 | US20030125240 Cyclic peptide antifungal agents |
| 07/03/2003 | US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment |
| 07/03/2003 | US20030124718 Cytolytic T lymphocyte (CTL); viricides; particle acceleration apparatus |
| 07/03/2003 | US20030124709 Preparation of a vaccine from enterotoxin and cytotoxins isolated from Salmonella sps. for protection against Salmonellosis in poultry, comprising: treating the said toxins with formalin in the predetermined ratio depending upon |